Skip to main content
SpringerLink
Log in

Celiac Disease and the Liver

  • Chapter
  • First Online:
Diagnosis and Management of Gluten-Associated Disorders

  • 529 Accesses

Abstract

Liver inflammation in celiac disease (CeD) is not an uncommon phenomenon, as up to 10% of patients develop elevated transaminases. In most cases, the transaminases will normalize with a gluten-free diet (GFD). However, up to 2% of these patients will be diagnosed with autoimmune hepatitis (AIH). Other associated liver diseases include cryptogenic hepatitis, primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), non-alcoholic fatty liver disease (NAFLD), and cirrhosis. This chapter reviews the hepatic involvement in CeD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Volta U, De Franceschi L, Lari F, et al. Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet. 1998;352:26–9.

    Article  CAS  PubMed  Google Scholar 

  2. Sainsbury A, Sanders DS, Ford AC. Meta-analysis: coeliac disease and hypertransaminasaemia. Aliment Pharmacol Ther. 2011;34:33–40.

    Article  CAS  PubMed  Google Scholar 

  3. Hagander B, Berg NO, Brandt L, et al. Hepatic injury in adult coeliac disease. Lancet. 1977;2:270–2.

    Article  CAS  PubMed  Google Scholar 

  4. Lindberg T, Berg NO, Borulf S, et al. Liver damage in coeliac disease or other food intolerance in childhood. Lancet. 1978;1:390–1.

    Article  CAS  PubMed  Google Scholar 

  5. Bonamico M, Pitzalis G, Culasso F, et al. Hepatic damage during celiac disease in childhood. Minerva Pediatr. 1986;38:959–63.

    CAS  PubMed  Google Scholar 

  6. Castillo NE, Vanga RR, Theethira TG, et al. Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population. Am J Gastroenterol. 2015. https://doi.org/10.1038/ajg.2015.192.

  7. Vajro P, Fontanella A, Mayer M, et al. Elevated serum amino transferase activity as an early manifestation of gluten-sensitive enteropathy. J Pediatr. 1993;122:416–9.

    Article  CAS  PubMed  Google Scholar 

  8. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology. 2007;46:1650–8.

    Article  CAS  PubMed  Google Scholar 

  9. Vajro P, Paolella G, Maggiore G, et al. Pediatric celiac disease, cryptogenic hypertransaminasemia, and autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2013;56:663–70.

    Article  CAS  PubMed  Google Scholar 

  10. Iorio R, Sepe A, Giannattasio A, et al. Lack of benefit of gluten-free diet on autoimmune hepatitis in a boy with celiac disease. J Pediatr Gastroenterol Nutr. 2004;39:207–10.

    Article  PubMed  Google Scholar 

  11. Maggiore G, Caprai S. Liver involvement in celiac disease. Indian J Pediatr. 2006;73:809–11.

    Article  PubMed  Google Scholar 

  12. Korponay-Szabo IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut. 2004;53:641–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ventura A, Magazzù G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP study Group for Autoimmune Disorders in celiac disease. Gastroenterology. 1999;117:297–303.

    Article  CAS  PubMed  Google Scholar 

  14. Davison S. Coeliac disease and liver dysfunction. Arch Dis Child. 2002;87:293–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Panetta F, Nobili V, Sartorelli MR, et al. Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management. Paediatr Drugs. 2012;14:35–41.

    Article  PubMed  Google Scholar 

  16. Novacek G, Miehsler W, Wrba F, et al. Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol. 1999;11:283–8.

    Article  CAS  PubMed  Google Scholar 

  17. vanGerven NM, Bakker SF, de Boer YS, et al. Seroprevalence of celiac disease in patients with autoimmune hepatitis. Eur J Gastroenterol Hepatol. 2014;26:1104–7.

    Article  CAS  Google Scholar 

  18. Caprai S, Vajro P, Ventura A, et al. SIGENP study Group for Autoimmune Liver Disorders in celiac disease. Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin Gastroenterol Hepatol. 2008;6:803–6.

    Article  PubMed  Google Scholar 

  19. Di Biase AR, Colecchia A, Scaioli E, et al. Autoimmune liver diseases in a paediatric population with celiac disease – a 10-year single-Centre experience. Aliment Pharmacol Ther. 2010;31:253–60.

    PubMed  Google Scholar 

  20. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of auto immune hepatitis. Hepatology. 2010;51:2193–213.

    Article  CAS  PubMed  Google Scholar 

  21. Mieli-Vergani G, Heller S, Jara P, et al. Autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2009;49:158–64.

    Article  CAS  PubMed  Google Scholar 

  22. Bridoux-Henno L, Maggiore G, Johanet C, et al. Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin Gastroenterol Hepatol. 2004;2:825–30.

    Article  PubMed  Google Scholar 

  23. Granito A, Muratori L, Muratori P, et al. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol. 2006;59:280–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Nastasio S, Sciveres M, Riva S, et al. Celiac disease-associated autoimmune hepatitis in childhood: long-term response to treatment. J Pediatr Gastroenterol Nutr. 2013;56:671–4.

    Article  CAS  PubMed  Google Scholar 

  25. Matthias T, Neidhöfer S, Pfeiffer S, et al. Novel trends in celiac disease. Cell Mol Immunol. 2011;8:121–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ludvigsson JF, Elfstrom P, Broome U, et al. Celiac disease and risk of liver disease: a general population based study. Clin Gastroenterol Hepatol. 2007;5:63–9.

    Article  PubMed  Google Scholar 

  27. Hay JE, Wiesner RH, Shorter RG, et al. Primary sclerosing cholangitis and celiac disease. A novel association. Ann Intern Med. 1988;109:713–7.

    Article  CAS  PubMed  Google Scholar 

  28. Volta U, Rodrigo L, Granito A, et al. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol. 2002;97:2609–13.

    Article  PubMed  Google Scholar 

  29. Al-Hussaini A, Basheer A, Czaja AJ. Liver failure unmasks celiac disease in a child. Ann Hepatol. 2013;12:501–5.

    Article  PubMed  Google Scholar 

  30. Logan RF, Ferguson A, Finlayson ND, et al. Primary biliary cirrhosis and coeliac disease: an association? Lancet. 1978;1:230–3.

    Article  CAS  PubMed  Google Scholar 

  31. Sorensen HT, Thulstrup AM, Blomqvist P, et al. Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut. 1999;44:736–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut. 1998;42:120–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Gillett HR, Cauch-Dudek K, Jenny E, et al. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can J Gastroenterol. 2000;14:672–5.

    Article  CAS  PubMed  Google Scholar 

  34. Dickey W, McMillan SA, Callender ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol. 1997;25:328–9.

    Article  CAS  PubMed  Google Scholar 

  35. Abenavoli L, Milic N, De Lorenzo A, et al. A pathogenetic link between non-alcoholic fatty liver disease and celiac disease. Endocrine. 2013;43:65–7.

    Article  CAS  PubMed  Google Scholar 

  36. Masarone M, Federico A, Abenavoli L, et al. Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials. 2014;9:126–33.

    Article  PubMed  Google Scholar 

  37. Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–5.

    Article  CAS  PubMed  Google Scholar 

  38. Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 2006;26:1021–8.

    Article  CAS  PubMed  Google Scholar 

  39. Vajro P, Paolella G, Fasano A. Microbiota and gut–liver axis: a mini-review on their influences on obesity and obesity related liver disease. J Pediatr Gastroenterol Nutr. 2013;56:461–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Freeman HJ. Hepatic manifestations of celiac disease. Clin Exp Gastroenterol. 2010;3:33–9.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Franzese A, Iannucci MP, Valerio G, et al. Atypical celiac disease presenting as obesity-related liver dysfunction. J Pediatr Gastroenterol Nutr. 2001;33:329–32.

    Article  CAS  PubMed  Google Scholar 

  42. Grieco A, Miele L, Pignatoro G, et al. Is coeliac disease a confounding factor in the diagnosis of NASH? Gut. 2001;49:596.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Bardella MT, Valenti L, Pagliari C, et al. Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig Liver Dis. 2004;36:333–6.

    Article  CAS  PubMed  Google Scholar 

  44. Rahimi AR, Daryani NE, Ghofrani H, et al. The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran. Turk J Gastroenterol. 2011;22:300–4.

    Article  PubMed  Google Scholar 

  45. Bakhshipour A, Kaykhaei MN, et al. Prevalence of coeliac disease in patients with non-alcoholic fatty liver disease. Arab J Gastroenterol. 2013;14:113–5.

    Article  PubMed  Google Scholar 

  46. Kaukinen K, Halme L, Collin P, et al. Celiac disease in patients with severe liver disease: GFD may reverse hepatic failure. World J Gastroenterol. 2002;122:881–8.

    Google Scholar 

  47. Rubio-Tapia A, Abdulkarim AS, Wiesner RH, et al. Celiac disease auto-antibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int. 2008;28:467–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Demir H, Yuce A, Caglar M, et al. Cirrhosis in children with celiac disease. J Clin Gastroenterol. 2005;39:630–3.

    Article  PubMed  Google Scholar 

  49. Pavone P, Gruttadauria S, Leonardi S, et al. Liver transplantation in a child with celiac disease. J Gastroenterol Hepatol. 2005;20:956–60.

    Article  PubMed  Google Scholar 

  50. Casswall TH, Papadogiannakis N, Ghazi S, et al. Severe liver damage associated with celiac disease: findings in six toddler-aged girls. Eur J Gastroenterol Hepatol. 2009;21:452–9.

    Article  PubMed  CAS  Google Scholar 

  51. Eapen CE, Nightingale P, Hubscher SG, et al. Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig Dis Sci. 2011;56:227–35.

    Article  CAS  PubMed  Google Scholar 

  52. Maiwall R, Goel A, Pulimood AB, et al. Investigation into celiac disease in Indian patients with portal hypertension. Indian J Gastroenterol. 2014;33:517–23.

    Article  PubMed  Google Scholar 

  53. Urganci N, Kalyoncu D. Response to hepatitis a and B vaccination in pediatric patients with celiac disease. J Pediatr Gastroenterol Nutr. 2013;56:408–11.

    Article  CAS  PubMed  Google Scholar 

  54. Sari S, Dalgic B, Basturk B, et al. Immunogenicity of hepatitis a vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2011;53:532–5.

    CAS  PubMed  Google Scholar 

  55. Sima H, Hekmatdoost A, Ghaziani T, et al. The prevalence of celiac auto-antibodies in hepatitis patients. Iran J Allergy Asthma Immunol. 2010;9:157–62.

    PubMed  Google Scholar 

  56. Noh KW, Poland GA, Murray JA. Hepatitis B vaccine non response and celiac disease. Am J Gastroenterol. 2003;98:2289–92.

    Article  PubMed  Google Scholar 

  57. Park SD, Markowitz J, Pettei M, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2007;44:431–5.

    Article  PubMed  Google Scholar 

  58. Vajro P, Paolella G, Nobili V. Children unresponsive to hepatitis B virus vaccination also need celiac disease testing. J Pediatr Gastroenterol Nutr. 2012;55:e131.

    Article  PubMed  Google Scholar 

  59. Chen J, Liang Z, Lu F, et al. Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with nonresponse to hepatitis B vaccine. Vaccine. 2011;29:706–11.

    Article  CAS  PubMed  Google Scholar 

  60. Van Heel DA, West J. Recent advances in coeliac disease. Gut. 2006;55:1037–46.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  61. Leonardi S, Spina M, Spicuzza L, et al. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies? Vaccine. 2009;27:6030–3.

    Article  CAS  PubMed  Google Scholar 

  62. Zingone F, Morisco F, Zanetti A, et al. Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents. Vaccine. 2011;29:1005–8.

    Article  CAS  PubMed  Google Scholar 

  63. Rostami K, Rostami-Nejad M. Vaccination in celiac disease. J Pediatr Gastroenterol Nutr. 2013;56:431–5.

    Article  Google Scholar 

  64. Filippelli M, Lionetti E, Gennaro A, et al. Hepatitis B vaccine by intradermal route in non-responder patients: an update. World J Gastroenterol. 2014;20:10383–94.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Leonardi S, Del Giudice MM, Spicuzza L, et al. Hepatitis B vaccine administered by intradermal route in patients with celiac disease unresponsive to the intra-muscular vaccination schedule: a pilot study. Am J Gastroenterol. 2010;105:2117–9.

    Article  CAS  PubMed  Google Scholar 

  66. Heshin-Bekenstein M, Turner D, Shamir R, et al. HBV revaccination with standard vs pre-S vaccine in previously immunized celiac patients: a randomized control trial. J Pediatr Gastroenterol Nutr. 2015;61:400–4.

    Google Scholar 

  67. Durante-Mangoni E, Iardino P, Resse M, et al. Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease on set and clinical outcome. J Clin Gastroenterol. 2004;38:901–5.

    Article  CAS  PubMed  Google Scholar 

  68. Rostami-Nejad M, Mohebbi SR, Rostami K, et al. Is there any association between chronic hepatitis C virus and celiac disease? Int J Infect Dis. 2010;14:e233.

    Article  Google Scholar 

  69. Adinolfi LE, Durante Mangoni E, Andreana A. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterol. 2001;96:607–8.

    Article  CAS  PubMed  Google Scholar 

  70. Monteleone G, Pender SL, Wathen NC, et al. Interferon-α drives T cell-mediated immunopathology in the intestine. Eur J Immunol. 2001;31:2247–55.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA

    Beshoy Yanny, Jasleen K. Grewal & Vijeta K. Vaswani

  2. Departments of Gastroenterology and Hepatology, University of California at Los Angeles, Los Angeles, CA, USA

    Beshoy Yanny, Jasleen K. Grewal & Vijeta K. Vaswani

Authors
  1. Beshoy Yanny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jasleen K. Grewal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vijeta K. Vaswani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Beshoy Yanny .

Editor information

Editors and Affiliations

  1. David Geffen School of Medicine at UCLA, University of California Los Angeles (UCLA) Celiac Disease Program, Los Angeles, CA, USA

    Guy A. Weiss

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yanny, B., Grewal, J.K., Vaswani, V.K. (2021). Celiac Disease and the Liver. In: Weiss, G.A. (eds) Diagnosis and Management of Gluten-Associated Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-56722-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-56722-4_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-56721-7

  • Online ISBN: 978-3-030-56722-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation